Retinoic Acid Excess Impairs Amelogenesis Inducing Enamel Defects. by Morkmued, Supawich (author) et al.
ORIGINAL RESEARCH
published: 06 January 2017
doi: 10.3389/fphys.2016.00673
Frontiers in Physiology | www.frontiersin.org 1 January 2017 | Volume 7 | Article 673
Edited by:
Ophir D. Klein,
University of California, San Francisco,
USA
Reviewed by:
Amel Gritli-Linde,
University of Gothenburg, Sweden
Lucia Jimenez-Rojo,
University of Zurich, Switzerland
*Correspondence:
Karen Niederreither
niederre@igbmc.fr
Specialty section:
This article was submitted to
Craniofacial Biology and Dental
Research,
a section of the journal
Frontiers in Physiology
Received: 08 November 2016
Accepted: 20 December 2016
Published: 06 January 2017
Citation:
Morkmued S, Laugel-Haushalter V,
Mathieu E, Schuhbaur B, Hemmerlé J,
Dollé P, Bloch-Zupan A and
Niederreither K (2017) Retinoic Acid
Excess Impairs Amelogenesis
Inducing Enamel Defects.
Front. Physiol. 7:673.
doi: 10.3389/fphys.2016.00673
Retinoic Acid Excess Impairs
Amelogenesis Inducing Enamel
Defects
Supawich Morkmued 1, 2, 3, 4, 5, Virginie Laugel-Haushalter 1, 2, 3, 4, Eric Mathieu 6,
Brigitte Schuhbaur 1, 2, 3, 4, Joseph Hemmerlé 6, Pascal Dollé 1, 2, 3, 4,
Agnès Bloch-Zupan 1, 2, 3, 4, 7, 8, 9, 10 and Karen Niederreither 1, 2, 3, 4, 7*
1Developmental Biology and Stem Cells Department, Institute of Genetics and Molecular and Cellular Biology (IGBMC),
Illkirch, France, 2Centre National de la Recherche Scientifique, UMR 7104, Illkirch, France, 3 Institut National de la Santé et de
la Recherche Médicale, U 964, Illkirch, France, 4Université de Strasbourg, Illkirch, France, 5 Pediatrics Department, Faculty of
Dentistry, Khon Kaen University, Khon Kaen, Thailand, 6Université de Strasbourg, INSERM UMR_1121, Biomaterials and
Bioengineering, Strasbourg, France, 7 Faculté de Chirurgie Dentaire, Université de Strasbourg, Strasbourg, France, 8 Faculté
de Médecine, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, Strasbourg, France,
9Hôpitaux Universitaires de Strasbourg, Pôle de Médecine et Chirurgie Bucco-Dentaires, Centre de Référence des
Manifestations Odontologiques des Maladies Rares, CRMR, Strasbourg, France, 10 Eastman Dental Institute, University
College London, London, UK
Abnormalities of enamel matrix proteins deposition, mineralization, or degradation
during tooth development are responsible for a spectrum of either genetic
diseases termed Amelogenesis imperfecta or acquired enamel defects. To assess if
environmental/nutritional factors can exacerbate enamel defects, we investigated the
role of the active form of vitamin A, retinoic acid (RA). Robust expression of RA-
degrading enzymes Cyp26b1 and Cyp26c1 in developing murine teeth suggested RA
excess would reduce tooth hard tissue mineralization, adversely affecting enamel. We
employed a protocol where RA was supplied to pregnant mice as a food supplement,
at a concentration estimated to result in moderate elevations in serum RA levels. This
supplementation led to severe enamel defects in adult mice born from pregnant dams,
with most severe alterations observed for treatments from embryonic day (E)12.5 to
E16.5. We identified the enamel matrix proteins enamelin (Enam), ameloblastin (Ambn),
and odontogenic ameloblast-associated protein (Odam) as target genes affected by
excess RA, exhibiting mRNA reductions of over 20-fold in lower incisors at E16.5.
RA treatments also affected bone formation, reducing mineralization. Accordingly,
craniofacial ossification was drastically reduced after 2 days of treatment (E14.5).
Massive RNA-sequencing (RNA-seq) was performed on E14.5 and E16.5 lower incisors.
Reductions in Runx2 (a key transcriptional regulator of bone and enamel differentiation)
and its targets were observed at E14.5 in RA-exposed embryos. RNA-seq analysis
further indicated that bone growth factors, extracellular matrix, and calcium homeostasis
were perturbed. Genesmutated in human AI (ENAM, AMBN, AMELX, AMTN,KLK4) were
reduced in expression at E16.5. Our observations support a model in which elevated RA
signaling at fetal stages affects dental cell lineages. Thereafter enamel protein production
is impaired, leading to permanent enamel alterations.
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INTRODUCTION
Enamel formation is a unique biomineralization process
involving a highly organized matrix protein scaffold deposition
and degradation, leading to hydroxyapatite crystal nucleation
generating a dense and tightly aligned network of hydroxyapatite
crystals. Mature enamel is the body’s hardest tissue. Ameloblasts
are cells of ectodermal origin responsible for enamel
development. These cells secrete enamel proteins, which are
required for correct mineralization and structural maturation.
Enamel proteins self-assemble and provide a matrix organization
that aligns the thin ribbons of calcium phosphate deposited
during enamel appositional growth. Enamel formation is
characterized by inductive, secretory, and maturation stages.
During the inductive stage, the inner enamel epithelium begins to
differentiate. Then at the secretory stage, polarized differentiated
ameloblasts release enamel proteins, contributing to the enamel
matrix (Bei, 2009). Finally at the maturation stage, ameloblasts
absorb water and organic matrix. This dehydration allows dense
crystal deposition. Mature enamel is thus extremely strong,
because of the density and fine organization of its crystal layers
(Bei, 2009; Simmer et al., 2010).
Amelogenesis imperfecta (AI) refers to a group of rare genetic
diseases presenting with defects in enamel formation either as
isolated trait, or in association with other symptoms. Patient
cases of AI are classified into hypoplastic, hypomineralized,
or hypomaturation categories based on enamel quantitative
or qualitative defects, i.e., thickness, hardness, and/or color.
To date, mutations in over 30 genes are associated with
non-syndromic or syndromic AI (Bloch-Zupan et al., 2012).
These diseases can be recapitulated in several mouse models.
For example, hypoplastic or aplastic enamel deficiencies are
produced by amelogenin (Amel), ameloblastin (Ambn), and
enamelin (Enam) mutations, recapitulating defects in patients
(Gibson et al., 2001; Fukumoto et al., 2004; Masuya et al.,
2005; Hu et al., 2008, 2014). Studies in mouse models have
contributed to understanding how defective ameloblast protein
secretion contributes to these diseases. For a given genetic defect,
interfamilial, intrafamilial, and individual intraoral variations in
phenotype severity are often seen, suggesting that environmental
factors come into play. Indeed, ameloblasts are highly sensitive
to their environment (Simmer et al., 2010). Body stressors
including high fever (Ryynänen et al., 2014), excess fluoride
(Yang et al., 2015), and endocrine disrupters such as bisphenol
A disrupt ameloblast function (Jedeon et al., 2014). It is likely
that a variety of factors contribute to clinical heterogeneity
found in AI and to acquired enamel defects such as molar
incisor hypomineralization (MIH) or hypomineralized second
primary molars (HSPM; Alaluusua, 2010; Jeremias et al.,
2013). Our objective is to discover novel factors initiating
and influencing enamel regulatory networks, with the aim of
designing new strategies to alleviate dental defects. To further
characterize nutritional and environmental factors regulating
enamel formation, we have focused on the role of retinoic
acid (RA), the main active form of vitamin A that plays key
roles during vertebrate development (Niederreither and Dollé,
2008). RA is the ligand for nuclear receptors (RARα, β, and
γ), which bind as heterodimers with RXRs to DNA regulatory
elements termed RA-response elements (RAREs, Rochette-Egly
and Germain, 2009). Through this mechanism, RA regulates
expression of various target genes (Balmer and Blomhoff,
2002). RA distribution within embryonic tissues is tightly
controlled through an interplay between enzymes involved in
its synthesis (mainly retinol dehydrogenase 10 and retinaldehyde
dehydrogenases [Raldh]1, 2, and 3) and catabolism (Cyp26A1,
B1, and C1). As both RA deficiency and excess results in
diverse developmental defects, the distribution of active retinoid
signaling requires tight regulation to limit potent adverse effects
(Rhinn and Dollé, 2012).
Expression of RA receptors, synthesizing, and catabolizing
enzymes has been detected in the developing teeth (Bloch-Zupan
et al., 1994; Berkovitz et al., 2001; Cammas et al., 2007). Severe
dietary vitamin A deficiency in rats leads to hypoplastic enamel,
enamel organ metaplasia, dentine dysplasia, and delayed tooth
eruption (Mellanby, 1941; Punyasingh et al., 1984; McDowell
et al., 1987). Hypervitaminosis A during rodent pregnancy
induces exencephaly and craniofacial malformations, along with
tooth fusions and supernumerary incisors (Knudsen, 1967 and
references therein). These effects may reveal an evolutionary role
of RA signaling in the posterior pharyngeal region controlling
tooth number (Seritrakul et al., 2012). In culture, RA excess
can retard molar growth (Mark et al., 1992), reduce ameloblast
differentiation (Kronmiller et al., 1992), and diminish tooth
alkaline phosphatase production (Jones et al., 2008). Retinoids
may also regulate incisor cervical loop maturation, increasing
mitosis and laminin gene expression (Bloch-Zupan et al.,
1994).
In vivo models to substantiate RA actions in tooth
development are lacking. Interestingly, though, Cyp26b1
knockout mice show a defect in maxillary bone compaction
around upper incisors (Maclean et al., 2009). Observing that
the fetal tooth has robust expression of Cyp26b1 and Cyp26c1
RA-degrading enzymes, we hypothesized that in vivo, conditions
of RA excess may have adverse effects on osteoblast and
ameloblast growth regulatory networks. We report that mice
born from dams exposed to RA during mid-late pregnancy
using a food-based supplementation suffer adult-stage enamel
hypoplasia. Effects were strongest when treatments began at
the tooth dental lamina-placode stage (E12.5), and continued
until early bell developmental stages. Reductions of Enam,
Ambn, and Odam mRNA expression in E16.5 lower incisors
were observed. High throughput RNA sequencing (RNA-seq)
analysis of lower incisors revealed that RA excess perturbs neural
crest lineage determinants and pro-ossification growth factor
and transcription networks. Combinatorial changes in collagen,
extracellular matrix, and calcium homeostasis genes occur at
E14.5, followed by a decrease at E16.5 of transcripts encoding
pre-ameloblast secretory-stage proteins. These alterations in
gene expression are observed several days before the ameloblast
lineage begins to differentiate. Retinoid excess targets fetal
odontoblasts, along with a range of epithelial enamel protein
targets. Our data provides potential avenues through which
environmental and nutritional changes may alter the penetrance
and expressivity of human enamel defects such as AI or MIH.
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MATERIALS AND METHODS
Ethics Statement
All animals were maintained and manipulated under animal
protocols in agreement with the French Ministry of Agriculture
guidelines for use of laboratory animals (IGBMC protocol 2012–
097) and with NIH guidelines, provided in the Guide for the
Care and Use of Laboratory Animals. CD1 mice were purchased
from Charles River, France. All-trans-RA (Sigma) suspended
in ethanol (5 mg/mL) was mixed into 50 mL water and 50 g
powdered food to a final concentration of 0.4 mg/g food. The
RA-containing food mixture (protected from light) was left in
the cage for the mice to feed ad libitum and changed every day.
Control groups consisted of CD1 mice given a matching food
treatment, but with no added RA. Equal numbers of RA-treated
samples vs. controls were randomly assigned to treatment or
control groups.
In situ Hybridization, Beta-Galactosidase
(X-gal) Staining, and Skeletal Analysis
In situ hybridization was performed using digoxigenin-
labeled RNA probes on 200µM vibratome sections of
paraformaldehyde-fixed embryos, which were processed
using an Intavis InSituPro robot, as described in detail on the
website http://empress.har.mrc.ac.uk/browser/ (Gene Expression
section). To analyze patterns of RA-response, we used the RARE-
hsp68-lacZ reporter transgenic line (Rossant et al., 1991). At
least 20 randomized fetal samples from control and matching
RA-treated samples were used to test each probe. All expression
studies were confirmed in at least 3 independent experiments.
X-gal assays were performed on 200µm vibratome sections.
Whole-mount fetal alizarin red/alcian blue staining was carried
out as described in http://empress.har.mrc.ac.uk/browser/ (Bone,
Cartilage, Arthritis, Osteoporosis section).
Real-Time Quantitative RT-PCR
RT-PCR assays were performed in duplicate on 3 RNA samples
for control or RA-treated incisors dissected at E14.5 and E16.5.
Total RNA (1µg) was subjected to real-time RT-PCR using
SYBR Green Reagents (Qiagen). RNA was extracted using the
RNeasy Micro-kit. Oligo-dT primed cDNAs were generated
using the Superscript II kit (Invitrogen). The incorporation of
SYBR Green into the PCR products was monitored in real-time
with a Roche 480 LightCycler. Sequences of primers are given
in supplemental Table S1. Target genes were normalized relative
to the glyceraldehyde-3-phosphate dehydrogenase (Gapdh)
housekeeping gene.
X-Ray Microtomography
Seven week-old mice were analyzed by X-ray micro-computed
tomography (micro-CT) using a Quantum FX micro-CT in
vivo Imaging System (Caliper Life Sciences), which operates
at 80 kV and 160µA, with high-resolution at 10–80µm pixel
size, to assay skull and tooth morphology. Data reconstructions
were performed with the Analyze software (v 11.0; Biomedical
Imaging Resource, Mayo Clinic, Rochester, MN).
Scanning Electron Microscopy
The lower incisors of 7 week-old control and RA-treated mice
were dissected out of the alveolar bone, rinsed, dehydrated in
a graded series of ethanol, and then transferred in a propylene
oxide/epon resin (v/v) solution. After embedding the teeth in
Epon 812 (Euromedex, Souffelweyersheim, France), they were
sectioned sagittally and polished with diamond pastes (Escil,
Chassieu, France). The embedded half incisors were etched
with a 20% (m/v) citric acid solution for 2min, rinsed with
distilled water, dehydrated in a graded series of ethanol and
dried at room temperature. The samples were then coated
with a gold-palladium alloy using a HUMMER JR sputtering
device (Technics, CA, USA) before performing scanning electron
microscopy with a Quanta 250 ESEM (FEI Company, Eindhoven,
The Netherlands) with an accelerating voltage of the electrons of
5 kV.
RNA Sequencing
Total RNA was extracted in quadruplicate from lower incisors
at E14.5 and 16.5 (2 days or 4 days after RA treatment) and
respective controls. The mRNA-seq libraries were prepared as
detailed in the Illumina protocol (supplemental Experimental
Procedures). Sequence reads mapped to the mouse reference
genome mm10/NCBI37 using Tophat. Only uniquely aligned
reads were retained for further analysis. Quantification of gene
expression was performed with HTSeq-0.6.1. (see http://www-
huber.embl.de/users/anders/HTSeq/doc/overview.html). For
each transcript the resulting reads per kilobase of exon model
per million mapped reads (RPKM) were converted to raw
read counts, which were then added for each gene locus. Data
normalization was performed as described (Anders and Huber,
2010) and resolved using the DESeq Bioconductor package.
Resulting p-values were adjusted for multiple testing, according
to Benjamini and Hochberg (1995). Regulated transcripts with
an RPKM of >2, an adjusted p < 0.050, and a log2 fold change
of >0.3 and < −0.3 at E14.5 and >0.5 and < −0.5 at E16.5 were
considered.
RESULTS
To analyze RA-dependent tooth alterations, we employed a
protocol where RA added to the food supply was administered
to pregnant CD1 mice (Niederreither et al., 2002), at a
concentration of 0.4 mg/g food beginning at E12.5 or later. The
treatment period began after craniofacial neural crest migration
into the head was complete (Minoux and Rijli, 2010), avoiding
earlier stage lethality due to exencephaly. In another study, HPLC
analysis carried out after similar RA treatment at 0.1 mg/g
food showed that serum RA levels were moderately increased
(∼20%) compared with untreated controls (Mic et al., 2003).
Treated dams bore litters with 50% lethality, typically with 5–
7 pups. Incisors in both groups erupted at the same age. Once
the pups reached adulthood (4–7 weeks-old), we compared 100
randomized control and RA-treated groups macroscopically for
dental defects. The labial side of rodent incisor (analog of the
crown and covered with enamel) normally has a yellow/orange
pigmentation, due to iron present at a net weight of about
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0.03% in enamel (Pindborg, 1953). It gives mouse teeth a
characteristic color, which is a dark orange in the upper incisors
(Figures 1A,E). When RA treatments were performed from
E12.5 to 16.5, they were found to produce a chalky lightening
and length reduction of incisors, changes more pronounced in
lower incisors (Figures 1B,F). The whiter color and less shiny
surface may reflect reduced enamel thickness typical of mouse
enamel hypoplasia models (Gibson et al., 2001; Masuya et al.,
2005; Hu et al., 2014). Treatments performed at later stages
(E13.5–16.5: Figures 1C,G, or E14.5–17.5: Figures 1D,H) had
less severe effects on enamel, suggesting RA has early roles
in the oral epithelium starting at the placode stage of tooth
initiation.
Samples shown in Figures 1A,E (WT) and B,F (RA-
treated) were analyzed by X-ray micro-computed tomography
(micro-CT). This analysis confirmed lower incisor shortening
(Figures 2A,B; Figure S1). Optical sections revealed a reduction
in enamelmineral density and thickness (molars in Figures 2C,E;
incisors in Figures 2D,F). Alveolar bone at the level of the
molars showed greater porosity in the RA-treated animals
(boxes in Figures 2C,E; Figure S2). Although retinoid gradients
shape pharyngeal tooth evolution (Seritrakul et al., 2012), our
micro-CT analysis revealed normal molar eruption and cusp
morphology (Figure S3), as predicted because RA treatments
are initiated at E12.5, after neural crest has completed its
migration into the jaw. This analysis also revealed no evident
signs of dental attrition from both groups. Figure 2G shows
scanning electron micrographs (SEM) of enamel prisms of
control lower incisor, exhibiting a well-organized decussating
pattern. This was disrupted following RA treatment. The most
outer enamel was less mineralized when compared with the
control tooth, as outer enamel appeared darker in RA-treated
animals. Enamel rods of RA-supplemented animals were less
densely packed, and as a consequence, areas normally filled
with interprismatic enamel seemed empty and showed holes-like
pattern (Figure 2H), similar to Enam haploinsufficent mice (Hu
et al., 2014).
Histological analysis of 1-week old mice after hematoxylin-
eosin staining confirmed that RA treatments produced a
shorter, smaller, and disorganized layer of ameloblasts in both
molars (Figures 3A,B) and incisors (Figures 3C–H). This
was clearly seen in the secretory zone, where ameloblasts
displayed disrupted epithelial sheet organization (Figure 3H).
In all treated samples, ameloblast adhesion to enamel
was impaired (Figures 3B,D,G,H). This was first seen
histologically as a detachment of the basement membrane,
likely causing preameloblast separation from forming
odontoblasts (Figure 3G, red arrowhead). Non-cellular
FIGURE 1 | RA excess during pregnancy produces stage-specific whitening and size reductions of mouse incisors. Enamel of the upper (A) and lower (E)
incisors of 7 weeks-old CD1 control (non-RA treated) mice has a characteristic yellow/orange color, which is consistently darker in the upper incisor. Retinoic acid
treatment from E12.5 to 16.5 reduces incisor length (by ∼20%) and lightens enamel color (B,F), suggesting reduced iron accumulation typical of murine models of
hypoplastic enamel formation. When RA treatment begins at E13.5 (C,G) or E14.5 (D,H), incisor length reductions and lightening of incisor color are progressively less
severe.
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FIGURE 2 | Micro-CT and SEM imaging of 7 weeks-old control (A,C,D,G) and RA-treated (B,E,F,H) mice. (A) Shows the typical length of a control incisor,
which is longer and exhibits an opaque whiter region reflecting high density where enamel is present. Comparing the E12.5–16.5 RA-treated mouse (B), incisor length
and enamel density are reduced throughout the tooth. Optical sections in a sagittal plane reveal regions with less surface enamel on lower molars of the treated
mouse (arrowheads in C,E). Optical cross-sections of the first molar and lower incisor (dotted lines in A,B) show reduced density of enamel in the lower incisor
(arrowheads in D,F). An increased porosity of the alveolar bone is observed below the molars in the RA-treated mouse (compare boxed areas in C,E). Scale bars: 1
mm. (G,H) Are SEM images from the central longitudinal plane of fully-formed lower incisor enamel from control and RA-treated samples (arrowheads in A,B). The
enamel of control presented a constant thickness and a clear decussating prism pattern (G). A reduced mineralization and impaired organization (especially in the
outer enamel) is observed in RA-treated samples (H). The area from which SEM views are taken is shown in the insert box. Scale bars: 10µm.
organic material was present between layers (Figure 3B,
black arrowhead). The lower incisor secretory zone enamel
layer was slightly thinner (Figure 3H), suggesting RA
treatment delayed enamel maturation and/or reduced overall
mineralization.
Enamel matrix proteins are secreted by ameloblasts and
form a matrix directing enamel mineral deposition. Among
these proteins, amelogenin is the most abundant (Eastoe,
1979). Enamel fails to form or is hypoplastic in amelogenin-
deficient mice (Gibson et al., 2001), and in Enam- or Ambn-
null mutant mice (Fukumoto et al., 2004; Masuya et al.,
2005; Hu et al., 2014). Our real-time RT-PCR analysis
of E16.5 lower incisors following E12.5–16.5 RA treatment
revealed up to 20-fold reductions in Enam, Ambn, and Odam
mRNAs (Figure 4). Notably, no RA-induced alterations in
Enam, Ambn, or Odam were observed at E14.5 (data not
shown).
To assess if reduced enamel protein expression was linked to
ectopic activation of RA signaling, we used RARE-hsp68-lacZ
transgenicmice as a reporter for RA activity (Rossant et al., 1991).
No expression was seen in the tooth germ areas at E13.5 (data
not shown), although activity was found in the mandible next to
the tooth germs at E14.5 (Figures 5A,B). This retinoid reporter
transgene exhibited low level of expression in both mandible and
maxilla adjacent to the growing incisors and molars in E16.5
untreated fetuses (Figure 5C and data not shown). In E16.5
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FIGURE 3 | Histological analysis of post-natal day 7 teeth. Hematoxylin and eosin stained sagittal sections of lower first molars of control (A) and E12.5–16.5
RA-treated (B) mice. The boxed areas in low-magnification insert panels are shown in detail. A black arrowhead in B points to cell debris accumulating between
separated tissue layers. Lower incisors of untreated (C,E,F) and RA-treated (D,G,H) mice. F, H are higher magnification views of the boxed areas in C,D. Comparing
the cervical loop of untreated (E) with RA-treated mice (G), it appears retinoid excess may disrupt the basement membrane (G, red arrowhead), potentially leading to
ameloblast detachment (B,D,H). The secretory stage ameloblast layer is also slightly thinner and enamel thickness reduced after RA treatment (B,D,H). Scale bars:
100µm. Abbreviations: A, ameloblasts; BM, basement membrane; D, dentin; E, enamel; O, odontoblasts; SI, stratum intermedium; SR, stellate reticulum.
fetuses following RA treatment from E12.5 to 16.5, domains
of RARE-lacZ activity broadly extended into alveolar bone and
surrounding mesenchyme, but appeared absent from enamel
organ and dental ectomesenchyme (Figure 5D and data not
shown). Note that very low levels of RA signaling may not be
detected by such a reporter transgene. Proper control of RA levels
is necessary for early neural crest patterning, but RA deficiency
does not alter first branchial arch formation (Niederreither
et al., 2000). To explore why RA activity was absent from
most tissues of the tooth buds, we examined expression of
CYP26 family cytochrome P450 enzymes specifically involved
in RA catabolism. At E13.5, Cyp26b1 expression (Figure 5E)
was found to be prominent in mesenchyme surrounding the
forming incisors. At E14.5,Cyp26c1 (Figure 5F) was prominently
expressed in the enamel organ, whereas a low amount of
Cyp26a1 transcripts was seen in the dental papilla (Figure 5F,
insert).
Excesses of vitamin A or RA lead to skeletal fragility by
reducing bone formation and by stimulating bone-resorbing
osteoclasts (Henning et al., 2015). In the Cyp26b1 mutant,
impaired RA catabolism causes long-bone fusions and induces
premature osteoblast differentiation intomineralizing osteocytes,
truncating bone development in the craniofacial region (Maclean
et al., 2009). Alizarin red/alcian blue staining of E14.5 skulls
2 days into RA regime revealed shortened mandibles, and
truncated regions of ossified maxilla and premaxilla in the
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FIGURE 4 | Real-time RT-PCR analysis shows reductions in
secretory-stage enamel gene expression. Enam, Ambn, and Odam
mRNA levels in lower incisor samples of E16.5 control mice (blue) vs.
E12.5–16.5 RA-treated mice. Target genes were normalized relative to Gapdh.
Mean (SD). Student t-test: ***p < 0.001, **p < 0.010, *p < 0.050.
RA-treated animals (Figures 6A,B). The skull frontal plate
was also smaller in treated animals, with less ossification.
Malformed Meckel’s cartilage and truncated mandibles could
lead to incisor shortenings. Skeletal staining performed at E15.5
confirmed RA-reduced mineralization (Figures 6C,D). RT-PCR
analysis showed reductions in Runx2 mRNA in both lower
incisor and adjacent alveolar bone at E14.5 in RA-treated
animals (Figures 6E,F). A 3-fold reduction in the expression
of this key target might account for reduced bone mineral
deposition (Ducy and Karsenty, 1998), and its mesenchymal
localization (Figure 6G) implies indirect enamel effects. To
exclude systemic non-specific RA effects, we cultured isolated
lower incisors or lower incisors with adjacent alveolar bone
from E13.5 embryos (Figure S4). When 10−8 M RA was added
to culture medium, Enam levels were dramatically reduced
in isolated incisor cultures, indicating RA acted directly on
tooth.
To compare global gene expression changes in control
vs. RA-treated samples, E14.5 and E16.5 lower incisors were
analyzed by high throughput RNA sequencing (RNA-seq).
Principal component analysis (PCA plot, Figure S5) and
scatter plots (Figure S6) revealed the overall changes observed
at E14.5 were tightly clustered, statistically significant, yet
often seen as net reductions of ∼20–50% (Table 1). RNA-seq
analysis confirmed broad effects of RA treatment affecting
mineralization-inducing pathways, extracellular collagens,
and calcium networks. Genes reduced in expression at E14.5
included Runx, Dlx, Bmp, and Shh, all known inducers of inner
enamel epithelium differentiation (Bei, 2009). Net reduction in
Runx2 and Dlx5 (Table 1) may act combinatorially to reduce
the bone biomarker BGLAP (osteocalcin, (Hassan et al., 2004)),
a target reduced by ∼2-fold at E16.5 in RA-treated samples
(Table 2). A novel RA-inhibited target is the matricellular
protein Smoc2, whose mutation in human produces oligodontia,
microdontia, abnormal root development, dentin dyplasia,
and reduced alveolar bone growth (Bloch-Zupan et al., 2011).
Retinoids are known to drive uncommitted progenitor cells
into neuronal lineages (Maden, 2007). Consistently, DAVID
(Database for Annotation, Visualization, and Integrated
Discovery) analysis revealed a functional enrichment score
of 1.4 E−6 for neuronal differentiation pathways. Increased
Neurogenin1 (Neurog1), Neurogenin2 (Neurog2), and the
notch target Hes5, are typical of an RA-induced neuronal
differentiation profile (Table S2). At E16.5, Enam was the
most reduced target (Table 2), also markedly reduced by
in situ hybridization analysis (Figure S7). Reductions in
ameloblastin, X- linked amelogenin, amelotin, and kallikrein-
related peptidase 4 (Klk4), all encoding enamel proteins
(Núñez et al., 2015), were observed (Table 2). Notably, these
reductions at E16.5 occur much earlier than the characterized
times of action of the corresponding proteins in inductive,
secretory, or maturation stages of rodent enamel development.
Odontoblast-originating signals control ameloblast induction
(Bei, 2009). Reductions in mineralization targets (alkaline
phosphatase), odontoblast structural proteins (dentin matrix
protein 1, dentin sialophosphoprotein), ossification biomarkers
(Bglap1/osteocalcin, Bglap2), and calcium homeostasis pathways
(calcitonin, vitamin D receptor) were all observed in E16.5
RA-treated samples. Table S3 summarizes how RA excess at
E16.5 increases the expression of genes involved in retinoid
signaling (including Cyp26b1), Wnt signaling, and neuronal
differentiation.
DISCUSSION
RA Excess Affects Enamel Matrix Protein
Expression Prior to Ameloblast
Differentiation
AI refers to rare, inherited diseases characterized by a defect
in enamel formation with clinical heterogeneity even within
the same family (Bloch-Zupan et al., 2012). These variations,
also observed in acquired enamel defects, have been proposed
to be due to environmental excess in fluoride (Yang et al.,
2015), or to other nutritional, environmental, or behavioral
changes (Li et al., 2013), along with genetic makeup of an
individual. Retinoids are regulators of skeletal growth and
patterning, known to lead to skeletal fragility when given in
excess (Henning et al., 2015). Since reciprocal interactions
between enamel organ and ectomesenchyme are necessary
for alveolar bone, periodontal, and tooth differentiation, we
examined if nutritional RA excess could have additional effects
on developing teeth. Prior to this study, little was known
about in vivo effects of RA on enamel cytodifferentiation. Here
we find that RA treatment at a defined window of murine
development resulted in permanent defects resembling human
AI. Ameloblast differentiation begins at the advanced bell
stage (∼E18.5 in mouse), when the inner enamel epithelial
originating cells express enamel secretory proteins and follow
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FIGURE 5 | Regions of RA activity and expression of RA-catabolizing enzymes in the developing teeth. X-gal analysis of RARE-hsp68-lacZ reporter
transgene activation in E14.5 (A,B) and E16.5 (C,D) untreated and RA-treated (E12.5–16.5) mice. At E14.5 in untreated mice, transgene activity can be observed
surrounding the tooth germ, and this activity is increased in treated mice. At E16.5, X-gal activity is detected in alveolar bone adjacent to upper (C,D) and lower (data
not shown) incisors (arrowhead). After RA treatment, reporter activity is increased in alveolar bone, but is never seen in developing teeth (compare high magnification
insert panels in C,D). At E13.5, Cyp26b1 is expressed in mesenchyme surrounding the lower incisors (E). At E14.5 a pronounced expression of Cyp26c1 is seen in
the enamel organ (F), whereas Cyp26a1 is expressed in the dental papilla epithelium (F, insert). Scale bars: 500µm. Abbreviations: B, bone; E, epithelium; M,
mesenchyme.
by processing enzymes (Bei, 2009; Bloch-Zupan et al., 2012).
Assuming normal rodent nocturnal feed, in our experimental
protocol RA exposure would begin at the bud stage of tooth
formation (E13.0). We observed that at E14.5, RA excess impairs
expression of Runx, Dlx, bone morphogenetic proteins, while
levels of enamel secretory proteins are not altered in either our
RNA-seq analysis or RT-PCR analysis at these same stages (data
not shown). RA excess changes likely occur prior to ameloblast
differentiation, with molecular alterations indicating effects on
pro-mineralization signaling.
Retinoids Have Early Targets in
Mineralized Tissue, and Later Effects on
Enamel Proteins
Enamel-reducing effects of RA supplementation at E13–14.5
coincide with the initial stages of intramembraneous ossification.
An early target is Runx2, a master regulator of skeletal
mineralization. Runx2−/− mouse mutants have a block in
endochondral and intramembraneous osteoblast maturation,
and site-specific reductions in collagen type I and alkaline
phosphatase expression (Ducy and Karsenty, 1998). Runx2−/−
mutants lack differentiated odontoblast and ameloblast matrices,
indicative of late bell-stage defects (D’Souza et al., 1999;
Bronckers et al., 2001). We observe RA-dependent Runx2
reductions at E14.5 bud stage incisors, but not at E16.5,
suggesting earlier effects. Cleidocranial dysplasia, an autosomal
dominant condition caused by mutations of RUNX2, likewise
results in insufficient dentin and enamel mineralization (Xuan
et al., 2010) and other dental anomalies (Camilleri and
McDonald, 2006). Terminal ameloblast differentiation requires
odontoblast-originating signals and matrix components (Balic
and Thesleff, 2015). Reports of evolutionarily conserved Runx2-
binding sites in Enam, Ambn, and Odam gene promoters
Dhamija and Krebsbach, 2001; Lee et al., 2010, suggested a
model of RA-inhibitory effects (Figure 7). Retinoid excess at
E14.5 would induce relatively small, yet combined reductions
in Runx2/3, Dlx3/5, and Bmp2/3, predominantly mesenchymal
targets that surround the bud stage tooth (Figure S8). By
E16.5 these factors collectively regulate early epithelial (enamel
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FIGURE 6 | Alizarin red/alcian blue analysis of E14.5 and E15.5 skeleton, RT-PCR and in situ hybridization analysis of Runx2 expression in lower
incisors and alveolar bone. Osteoblast mineralization marked by red alizarin staining in untreated E14.5 (A) and E15.5 (C) heads is reduced in RA-treated (B,D)
parietal bone (red arrowhead) and mandible (black arrowhead) at equivalent stages. Scale bars: 1 mm. RT-PCR analysis of Runx2 mRNA at E14.5 shows significant
reductions following RA treatments in mandibular bone (E) and lower incisor (F). Target genes were normalized relative to Gapdh. Mean (SD). Student t-test:
*p < 0.05. (G) In situ hybridization detection of Runx2 transcripts in E14.5 lower incisors (in absence of RA treatment).
organ) expression of Enam, Ambn, and Amelx. This is plausible
because these enamel targets possess evolutionarily conserved
binding site-motifs in their proximal promoters (Loots et al.,
2002; Cartharius et al., 2005; Figure 7C; Table S4). While
the bell stage tooth reacts to the high retinoid environment
by up-regulating Cyp26b1 levels (Table S3), this change is
insufficient to offset strong reductions in enamel matrix
protein secretion, which then induce ameloblast differentiation
defects.
Many Enamel Targets Are in the Secretory
Phosphoprotein-Encoding (SCPP) Gene
Cluster
Our RNA-seq analysis on the whole lower incisors uncovered
many genes significantly reduced at E16.5 that regulate
ameloblast differentiation, enamel formation, and dentin/bone
development (Table 2). Hence combinatorial deficits in enamel
secretory protein expression included reductions in X-linked
amelogenin (AMELX, OMIM: 300391) (Gibson et al., 2001;
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TABLE 1 | Genes encoding regulators of bone growth, collagens, and
proteins involved in calcium signaling and homeostasis, retinoid, and Shh
pathways, reduced in expression in E14.5 RA-treated lower incisors.
Symbol Name FC log2 p-value
BONE/OSTEOBLAST GROWTH
Bmp2 Bone morphogenetic protein 2 −0.35 1.08 E-02
Bmp3 Bone morphogenetic protein 3 −0.33 1.93 E-02
Bmp5 Bone morphogenetic protein 5 −0.43 1.72 E-02
Ostn Osteocrin −1.30 8,96 E-05
Sp7 Sp7 transcription factor 7 −0.80 2,62 E-05
Smoc2 SPARC modular calcium binding 2 −0.73 1,74 E-08
Runx2 Runt related transcription factor 2 −0.38 2.98 E-02
Runx3 Runt related transcription factor 3 −0.62 7.01 E-06
Dlx5 Distal-less homeobox 5 −0.58 1.64 E-03
Dlx3 Distal-less homeobox 3 −0.53 8.37 E-03
Mef2c Myocyte enhancer factor 2C −0.58 6.33 E-05
Ltbp2 Latent transforming growth factor β binding
protein 2
−0.86 1.98 E-06
Fgf10 Fibroblast growth factor 10 −0.42 4.17 E-04
Fam20a Family with sequence similarity 20A −0.64 2.71 E-04
Tnn Tenascin N −1.18 2.01 E-10
Sox6 SRY (sex determining region Y)-box 6 −0.41 1.20 E-02
Tgfb3 Transforming growth factor β 3 −0.31 1.45 E-04
COLLAGEN
Col1a1 Collagen, type I, α 1 −0.61 6.25 E-03
Col1a2 Collagen, type I, α 2 −0.43 3.62 E-02
Col5a1 Collagen, type V, α 1 −0.37 1,39 E-04
Col6a3 Collagen, type VI, α 3 −0.42 8.34 E-05
Col8a1 Collagen, type VIII, α 1 −0.79 3.74 E-04
Col8a2 Collagen, type VIII, α 2 −0.53 1.25 E-04
Col12a1 Collagen, type XII, α 1 −0.63 1.43 E-04
CALCIUM SIGNALING AND HOMEOSTASIS
Capn3 Calpain 3 −1.03 1.78 E-03
Otof Otoferlin −0.82 3.68 E-03
Kcnma1 Potassium calcium-activated channel Mα 1 −0.54 8.47 E-03
Cacna2d2 Calcium channel, voltage dependent, α2/δ2 −0.48 2.26 E-03
RETINOID SIGNALING
Aldh1a1 Retinaldehyde dehydrogenase 1 −0.80 1.22 E-02
Aldh1a3 Retinaldehyde dehydrogenase 3 −0.69 2.70 E-03
Rbp2 Retinol binding protein 2 −0.86 4.68 E-02
Cyp26c1 Cytochrome P450 26c1 −0.29 3.77 E-01
SHH SIGNALING
Ihh Indian hedgehog −1.40 1.84 E-06
Hhip Hedgehog-interacting protein −0.65 1.64 E-05
Ptch1 Patched 1 −0.42 3.04 E-02
Data are presented as log2 fold changes in RA-treated vs. control samples: for instance,
a FC log2 value of−1.00 will correspond to a 50%mRNA level in the RA-treated samples.
Barron et al., 2010), AMBN (OMIM: 601259) (Fukumoto
et al., 2004), AMTN (OMIM: 610912) (Nakayama et al., 2015),
along with Odam (OMIM: 614843). These genes belong to
the evolutionarily-related SCPP gene cluster, a linked group of
genes also containingmembers regulating skeletal mineralization
(Kawasaki and Weiss, 2008). These SCPP enamel proteins
contain structural domains promoting calcium sequestration and
TABLE 2 | Summary of genes encoding enamel proteins, extracellular
matrix components, proteins involved in bone growth pathways, or
calcium and iron signaling/homeostasis, all reduced in expression
according to RNA-seq analysis of E16.5 RA-treated lower incisors.
Symbol Name FC log2 p-value
ENAMEL MATRIX PROTEINS
Enam Enamelin −3.47 4.99 E-013
Amtn Amelotin −1.85 1.53 E-004
Amelx Amelogenin, X-linked −1.7 1.01 E-004
Ambn Ameloblastin −1.42 1.78 E-003
ENAMEL MODIFICATION
Klk4 Kallikrein peptidase 4 −1.62 1.14 E-003
Ppara Peroxisome proliferator activated
receptor α
−0.74 1.55 E-002
Fam20c Family with sequence similarity 20, C −0.66 7.31 E-003
BONE GROWTH FACTOR PATHWAYS
Bglap Bone gamma carboxyglutamate protein −1.67 6.06 E-004
Bglap2 Bone gamma-carboxyglutamate protein 2 −1.15 2.41 E-002
Comp Cartilage oligomeric matrix protein −2.89 3.00 E-013
Phex Phosphate endopeptidase X-linked −1.01 4.10 E-002
Alpl Alkaline phosphatase −0.94 5.79 E-006
Col11a1 Collagen, type XI, α 1 −1.16 4.60 E-006
Col11a2 Collagen, type XI, α 2 −1.4 5.72 E-004
Col13a1 Collagen, type XIII, α 1 −1.34 7.25 E-008
EXTRACELLULAR MATRIX
Dmp1 Dentin matrix protein 1 −0.94 7.47 E-002
Dspp Dentin sialophosphoprotein −0.85 9.79 E-002
Postn Periostin −0.56 1.39 E-004
CALCIUM SIGNALING AND HOMEOSTASIS
Camk2a Calcium/calmodulin protein kinase II α −1.31 4.72 E-005
Camk2b Calcium/calmodulin protein kinase II β −1.41 1.33 E-005
Smoc2 SPARC related modular calcium binding 2 −0.51 5.02 E-004
Calcr Calcitonin receptor −2.91 1.22 E-014
Vdr Vitamin D receptor −1.45 6.81 E-008
Slc8a3 Solute carrier family 8 (sodium/calcium
exchanger) 3
−1.17 3,80 E-003
Pth1r Parathyroid hormone 1 receptor −1.00 3.31 E-006
Ramp1 Receptor (calcitonin) activity modifying
protein1
−1.09 1.00 E-006
IRON HOMEOSTASIS
Hfe2 Hemochromatosis type 2 −1.04 3.70 E-002
Tfr2 Transferrin receptor 2 −0.99 1.34 E-003
Data are presented as log2 fold changes (FC log2) in RA-treated vs control samples:
for instance, a FC log2 value of −1.00 will correspond to a 50% mRNA level in the RA-
treated samples. Adjusted p-value takes into account a false discovery rate wherein 5%
of samples with a p-value of 0.050 will result in false positives.
regulating crystal adsorption (Addison and McKee, 2010), and
their mutations produce hypomineralized enamel phenotypes
including altered prism patterning and increased cellular
apoptosis in both patients and mouse models (Fukumoto et al.,
2004; Bei, 2009; Hu et al., 2014; Núñez et al., 2015). Reductions
in the SCPP cluster appeared specific to enamel expression.
Other enamel-regulating targets included the kallikrein-related
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FIGURE 7 | Model of how RA excess impairs enamel formation. Dental
mesenchyme (green) and oral epithelium (red) have reciprocal interactions
during tooth development (Balic and Thesleff, 2015) (A,B). (A) Normally the
entire developing tooth is shielded from RA by actions of Cyp26 RA-degrading
enzymes. This allows proper expression of Runx2/3, Dlx3/5, and Bmp2/3 in
the mesenchyme condensing next to the oral epithelium at the bud stage (B).
These targets are reduced by excess RA. Enam, Ambn, and Amelx exhibit
strong reductions at the late bell stage, impairing enamel crystallization (C).
The binding site motifs of Runx2/3, Dlx3/5, and Smad2/3/4 were obtained
from the JASPAR database (http://jaspar.genereg.net) and used to find
potential binding sites in conserved regions using the rVISTA database
(http://genome.lbl.gov/vista/index.shtml).
peptidase 4, essential for removing enamel proteins and bio-
mineralization (OMIM: 603767), the peroxisome proliferator-
activated receptor (PPAR) alpha, required to achieve normal
enamel mineralization (OMIM: 170998) (Sehic et al., 2009),
and FAM20C, whose mutation produces severe enamel defects
in human and mouse (Wang et al., 2012; Acevedo et al.,
2015).
RA Excess Alters the Osteoblast,
Odontoblast, and Ameloblast Lineages
Over 80 years ago, severe nutritional vitamin A deficiency
was reported to reduce enamel formation (Mellanby, 1941),
but since this time no genetic models of RA deficiency have
been reported with ameloblast or other primary tooth defects.
No defects are observed in mouse mutants for the RA-
synthesizing enzymes Raldh2 and Raldh3 (Dupé et al., 2003,
our unpublished observations), implicating a more severe RA
deficiency is required. More likely vitamin A intake levels
are usually quite high, hence cellular RA levels need to be
reduced during ossification. Both hypervitaminosis A and very
low serum retinol levels produce skeletal fragility, poor bone
health, and osteoporosis risk (Henning et al., 2015; Green
et al., 2016). During mineralization, site-specific increases in
CYP26 enzymes are required for bone formation (Minegishi
et al., 2014). Cyp26b1−/− mutants have truncated, under-
ossified mandibles, possibly due to RA excess perturbing
neural crest migration, or alternatively to defects in osteoblast
maturation. Incisor defects, while noted, were not characterized
(Maclean et al., 2009). Human mutations (both null and
hypomorphic) for this RA-catabolizing enzyme produce calvarial
hypoplasia and craniosynostosis (Laue et al., 2011). In our
experiments, Cyp26b1 is potently induced in RA-treated
E16.5 incisors (Table S3). Even so, enamel defects are still
observed.
The dentino-alveolar bone complex regulates tooth
development. We observe rapid in vivo effects of RA reducing
Runx2, and its collagenous and mineralization targets. This
rapid rodent response to hypervitaminosis A (Lind et al.,
2013) is similar to effects in humans (Henning et al., 2015).
These RA excesses target enamel matrix protein production.
Phenotypic differences in AI severity have been described
between family members with identical mutations (see Prasad
et al., 2016, for a recent list). Affected patients could be sensitized
to otherwise benign alteration in vitamin consumption,
RA catabolism pathways, or defects in the tooth and bone
biosynthesis programs. Accumulating mutations might sensitize
fetal development to environmental factors, including nutrition,
explaining variability in AI morphogenetic phenotypes.
Similar models have been proposed for RA interactions
with the DiGeorge/chromosome 22q1 deletion syndrome
(Maynard et al., 2013). Even physiological RA excesses, in
the context of additional genetic alterations (which otherwise
would produce benign changes) could have net consequences
contributing to clinical variations in oral manifestations of rare
diseases.
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